Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v8-EN
Language French English
Date Updated 2020-03-05 2020-03-05
Drug Identification Number 02404044 02404044
Brand name XERESE XERESE
Common or Proper name XERESE XERESE
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C. VALEANT CANADA LP/VALEANT CANADA S.E.C.
Ingredients ACYCLOVIR HYDROCORTISONE ACYCLOVIR HYDROCORTISONE
Strength(s) 5% 1% 5% 1%
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL
Packaging size n/a n/a
ATC code D06BB D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-06 2020-01-06
Estimated end date
Actual end date 2020-03-02 2020-03-02
Shortage status Resolved Resolved
Company comments waiting QA release waiting QA release
Health Canada comments